Detalhe da pesquisa
1.
Up-Regulation of DNA Damage Response Signaling in Autosomal Dominant Polycystic Kidney Disease.
Am J Pathol
; 191(5): 902-920, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33549515
2.
Role of cyclin-dependent kinase 2 in the progression of mouse juvenile cystic kidney disease.
Lab Invest
; 100(5): 696-711, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31915367
3.
The role of DNA damage as a therapeutic target in autosomal dominant polycystic kidney disease.
Expert Rev Mol Med
; 21: e6, 2019 11 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31767049
4.
Process evaluation of TXT2BFiT: a multi-component mHealth randomised controlled trial to prevent weight gain in young adults.
Int J Behav Nutr Phys Act
; 13: 7, 2016 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-26785637
5.
Inter-relationships between proprotein convertase subtilisin/kexin type 9, apolipoprotein C-III and plasma apolipoprotein B-48 transport in obese subjects: a stable isotope study in the postprandial state.
Clin Sci (Lond)
; 128(6): 379-85, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25291660
6.
Supplementation with n3 fatty acid ethyl esters increases large and small artery elasticity in obese adults on a weight loss diet.
J Nutr
; 143(4): 437-41, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23365106
7.
Omega-3 fatty acid ethyl ester supplementation decreases very-low-density lipoprotein triacylglycerol secretion in obese men.
Clin Sci (Lond)
; 125(1): 45-51, 2013 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-23356247
8.
Prescribed Water Intake in Autosomal Dominant Polycystic Kidney Disease.
NEJM Evid
; 1(1): EVIDoa2100021, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38319283
9.
Nonalcoholic fatty liver disease as the transducer of hepatic oversecretion of very-low-density lipoprotein-apolipoprotein B-100 in obesity.
Arterioscler Thromb Vasc Biol
; 30(5): 1043-50, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20150556
10.
Effect of Early and Delayed Commencement of Paricalcitol in Combination with Enalapril on the Progression of Experimental Polycystic Kidney Disease.
J Cardiovasc Dev Dis
; 8(11)2021 Oct 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34821697
11.
Long-term dietary nitrate supplementation does not reduce renal cyst growth in experimental autosomal dominant polycystic kidney disease.
PLoS One
; 16(4): e0248400, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33886581
12.
Regression of Peritubular Capillaries Coincides with Angiogenesis and Renal Cyst Growth in Experimental Polycystic Kidney Disease.
Int J Nephrol Renovasc Dis
; 13: 53-64, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32280260
13.
Assessment of Dietary Sodium Intake Using the Scored Salt Questionnaire in Autosomal Dominant Polycystic Kidney Disease.
Nutrients
; 12(11)2020 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33147804
14.
Increased water intake reduces long-term renal and cardiovascular disease progression in experimental polycystic kidney disease.
PLoS One
; 14(1): e0209186, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30601830
15.
Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD).
BMJ Open
; 8(1): e018794, 2018 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29358433
16.
Plasma apolipoprotein B-48 transport in obese men: a new tracer kinetic study in the postprandial state.
J Clin Endocrinol Metab
; 99(1): E122-6, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24203058
17.
Effect of ω-3 fatty acid ethyl esters on apolipoprotein B-48 kinetics in obese subjects on a weight-loss diet: a new tracer kinetic study in the postprandial state.
J Clin Endocrinol Metab
; 99(8): E1427-35, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24606094
18.
Apolipoprotein B-48 as a determinant of endothelial function in obese subjects with type 2 diabetes mellitus: effect of fenofibrate treatment.
Atherosclerosis
; 221(2): 484-9, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22341868
19.
Effect of laparoscopic sleeve gastrectomy on elevated C-reactive protein and atherogenic dyslipidemia in morbidly obese patients.
Clin Biochem
; 44(4): 342-4, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21167144
20.
Apolipoprotein A-II and adiponectin as determinants of very low-density lipoprotein apolipoprotein B-100 metabolism in nonobese men.
Metabolism
; 60(10): 1482-7, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21550083